March 12, 2020
10-11 a.m.
University Club, Ballroom A
123 University Place, Pittsburgh, PA 15260
The American Heart Association is the largest non-governmental, non-profit funder of cardiovascular and cerebrovascular research in the US.
AHA recently adopted a new mission: To Be a Relentless Force for a World of Longer, Healthier Lives.
As AHA’s mission has broadened, so too have opportunities for investigators who might not typically consider applying to AHA for support.
Those attending this session will learn about some of these additional opportunities, and about the research portfolio generally, including:
Glenn H. Dillon, PhD, is Director of Research Operations for the American Heart Association, the largest not-for-profit funder of cardiovascular disease and stroke in the United States.
In this role, he is responsible for oversight of AHA’s research portfolio, which exceeded $180M in FY2019. Prior to joining AHA in January 2018, Glenn had spent his career in academia.
Most recently, he was Professor of Pharmacology and Neuroscience and Vice Provost for Health Institutes at University of North Texas Health Science Center. He also served for several years as Vice President for Research at UNTHSC.
While at West Virginia University, he was Professor of Physiology and Pharmacology at West Virginia University Health Sciences Center’s School of Medicine, and Vice President for Research and Graduate Education. Glenn earned his Ph.D. from the Department of Physiology and Biophysics at the University of Illinois Urbana-Champaign, then did postdoctoral research in molecular neuropharmacology in Central Nervous Systems Diseases Research at the Upjohn Company in Kalamazoo, MI. His research lab focused on the molecular pharmacology and cellular physiology of ligand-gated ion channels in the brain.
